7 results
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
) Treatment - GDMT ... recommended by the ACC ... /ambcarerx #CHF ... #sCHF #HeartFailure ... #HFrEF #Pharmacology
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
2017 ACC/AHA/HFSA ... Society of America #HFrEF ... #HeartFailure # ... Management #CHF ... ACCAHA2017 #cardiology #treatment
Iron Deficiency in Heart Failure - Diagnosis and Treatment Algorithm
Diagnosis: Ferritin <100 ng/mL (absolute ID) OR
Diagnosis and Treatment ... Guidelines: • ACC ... patients with HFrEF ... iron #deficiency #CHF ... #HFrEF #heartfailure
Heart failure with Reduced Ejection Fraction (HFrEF)
Clinical Presentation
1. Typical symptoms: dyspnea, orthopnea paroxysmal noctumal dyspnea, fatigue,
Ejection Fraction (HFrEF ... endomyocardial biopsy Pharmacology ... : • ACE Inhibitors ... #heartfailure # ... management #cardiology #pharmacology
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
functional ID) Treatment ... composite endpoint of all-cause ... iron #deficiency #CHF ... #HFrEF #heartfailure
Severe Heart Failure & Cardiogenic Shock - Management Checklist 
Evaluation 
 - EKG & echocardiography
milrinone) for HFrEF ... Revascularization, treatment ... NSAlDs, ACE-inhibitors ... #Checklist #CHF ... #Cardiogenic #HeartFailure
Veltassa (Patiromer) 
MECHANISM: Potassium Binder 
INDICATION: Treatment of Hyperkalemia 
FORMULATION: Powder for oral suspension 
DOSING: 8.4
INDICATION: Treatment ... patients with CKD, HF ... ACE inhibitors, ... #Hyperkalemia #Pharmacology